Zhou Zanmei, Sun Xiuyan, Guo Chunmei, Sun Ming-Zhong, Liu Shuqing
Department of Biochemistry, Dalian Medical University, Dalian, Liaoning 116044, P.R. China.
Department of Laboratory Medicine, The Affiliated Hospital of Dalian University, Dalian, Liaoning 114012, P.R. China.
Oncol Lett. 2019 Jun;17(6):5169-5174. doi: 10.3892/ol.2019.10194. Epub 2019 Mar 27.
Lymphatic metastasis is a major mechanism of tumor metastasis. The present study aimed to investigate the association of CRKII, a member of the CRK family, with the malignant behaviors of a murine hepatocarcinoma Hca-P cell line, with a lymph node metastatic rate of ~25%. Total mRNA was extracted from Hca-P cells, and then the murine CRKII gene was amplified by polymerase chain reaction and cloned into the pEASY-blunt cloning vector. Subsequently, the recombinant pcDNA3.1/V5-HisB-CRKII plasmid was constructed and transfected into Hca-P cells. Western blotting indicated that the CRKII expression level in pcDNA3.1/V5-HisB-CRKII-Hca-P cells was increased by ~185%, compared with pcDNA3.1/V5-HisB-Hca-P cells. The stable overexpression of CRKII enhanced the proliferation ability, as measured with a Cell Counting Kit-8 assay, and the colony forming capacity was measured with a soft agar colony forming assay for Hca-P cells. The migration and invasion capacities of Hca-P cells were increased by ~179 and 156% in Hca-P cells, respectively, following the stable upregulation of CRKII. Collectively, the recombinant pcDNA3.1/V5-HisB-CRKII-Hca-P plasmid was constructed successfully. Additionally, the CRKII expression level was positively associated with the proliferation, migration and invasion malignant properties of Hca-P cells.
淋巴转移是肿瘤转移的主要机制。本研究旨在探讨CRK家族成员CRKII与小鼠肝癌Hca-P细胞系恶性行为的关系,该细胞系的淋巴结转移率约为25%。从Hca-P细胞中提取总mRNA,然后通过聚合酶链反应扩增小鼠CRKII基因,并将其克隆到pEASY-blunt克隆载体中。随后,构建重组pcDNA3.1/V5-HisB-CRKII质粒并转染到Hca-P细胞中。蛋白质免疫印迹法表明,与pcDNA3.1/V5-HisB-Hca-P细胞相比,pcDNA3.1/V5-HisB-CRKII-Hca-P细胞中CRKII的表达水平提高了约185%。通过细胞计数试剂盒-8检测法测定,CRKII的稳定过表达增强了Hca-P细胞的增殖能力,并用软琼脂集落形成试验测定了其集落形成能力。在CRKII稳定上调后,Hca-P细胞的迁移和侵袭能力分别提高了约179%和156%。总的来说,成功构建了重组pcDNA3.1/V5-HisB-CRKII-Hca-P质粒。此外,CRKII表达水平与Hca-P细胞的增殖、迁移和侵袭恶性特性呈正相关。